Back to the Drawing Board for Fujifilm Holdings’ Favipiravir in Japan as it Must Now Execute Another Phase 3 Clinical Trial
Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for […]
